AR and prostate neoplasm: AR is targeted by several drugs used in the treatment of prostatic neoplasms, such as apalutamide, bicalutamide, diethylstilbestrol, enzalutamide, flutamide, and nilutamide (triangle in the Fig. 4A, source: DrugBank).